When was Allele Biotech founded?

Allele Biotech was founded in 1999 and raised its 1st funding round 14 years after it was founded.

Where is Allele Biotech located?

Allele Biotech is headquartered in San Diego, United States.

How many employees does Allele Biotech have?

As of Jun 30, 2026, the latest employee count at Allele Biotech is 30.

Is Allele Biotech a funded company?

Allele Biotech is a funded company, having raised a total of $18M across 10 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jun 10, 2013.

When was the latest funding round of Allele Biotech?

Allele Biotech's latest funding was a $***** Grant (prize money) round on Sep 01, 2018, with participation from 1 investor.

Where does Allele Biotech rank among its competitors?

Allele Biotech ranks 5th amongst 282 active competitors, of which 16 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Y-Biologics, which secured $25.2M in Aug, 2025.

Who are the top competitors of Allele Biotech?

Allele Biotech's top competitors include Sino Biological, Y-Biologics and GenScript. Among them, Y-Biologics secured the most recent funding round in August, 2025.

Allele Biotech - 2026 Company Profile, Funding & Competitors

Company Details

cGMP iPSCs and cell therapy CDMO accelerating regenerative medicine programs. This company is a dedicated provider of clinical-grade induced pluripotent stem cells (iPSCs) and comprehensive cell therapy contract development and manufacturing organization (CDMO) services. They offer an all-in-one solution encompassing iPSCs, allied technologies, and CDMO services to accelerate life-saving immuno-oncology and regenerative medicine cell therapy programs. Their expertise spans cGMP iPSC manufacturing, single-cell cloning, quality control, consulting, and banking. They utilize a proprietary mRNA system to generate footprint-free, feeder-free, and xeno-free iPSCs, ensuring consistency and scalability for cell therapy development. Services include custom development, off-the-shelf iPSCs, genome editing (CRISPR), endotoxin testing, and partnership for autologous cell therapy. They provide a clean slate for cell therapy development, meeting strict regulatory standards for seamless transition from scientific development to commercial deployment.

Website: allelebiotech.com
Social

Key Metrics

Founded Year

1999

Location

San Diego, United States

Stage

Series B

Total Funding

$18M in 10 rounds

Latest Funding Round

Grant (prize money), Sep 01, 2018, $*****

Investors

HHS & 2 more

Ranked

5^th among 282 active competitors

Employee Count

30 as on Jun 30, 2026

Similar Companies

Sino Biological & 337 more

View Allele Biotech's full profile

Allele Biotech has raised a total funding of $18M over 10 rounds. Its first funding round was on Jun 10, 2013. Its latest funding round was a Grant (prize money) round on Sep 01, 2018 for $*****. 1 investor participated in its latest round. Allele Biotech has 3 institutional investors.

Here is the list of recent funding rounds of Allele Biotech:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 01, 2018	6871788	Grant (prize money)	7681915	4667401	5403222	3501813
Oct 26, 2016	1566106	Series B	9160401	7527148	1168888	4294434
Sep 30, 2016	7392181	Grant (prize money)	7278324	7497788	3955753	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Allele Biotech's funding rounds and investors

Allele Biotech's employee count trend

Allele Biotech has 30 employees as of Jun 26. Here is Allele Biotech's employee count trend over the years:

Uncover Allele Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Allele Biotech include Sino Biological, Y-Biologics and GenScript. Here is the list of Top 10 competitors of Allele Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	67/100
2nd	Y-Biologics 2007, Daejeon (South Korea), Public	Developer of antibodies for the treatment of multiple diseases	$42.1M	InterVest, IMM Investment & 14 others	56/100
3rd	GenScript 2002, Piscataway (United States), Public	Provider of reagents and instruments for life sciences research	$15M	Kleiner Perkins, Vermögensclub & 1 others	55/100
4th	Shanghai OPM Biosciences 2013, Pudong (China), Series B	Antibody culture media and vaccine culture products developer	$14.4M	CPE, China Life Great Health Fund & 5 others	54/100
5th	Allele Biotech 1999, San Diego (United States), Series B	cGMP iPSCs and cell therapy CDMO accelerating regenerative medicine programs	$18M	HHS, NIH & 1 others	48/100
6th	Mabtech 1986, Nacka (Sweden), Acquired	Develops antibodies and ELISA kits	-	Merieux Equity Partners, IK Partners & 1 others	52/100
7th	Pixelgen Technolgies 2020, Stockholm (Sweden), Series A	Developer of ground-breaking technologies for biomedical research and diagnostics	$6M	Industrifonden, Navigare Ventures & 1 others	52/100
8th	ITBMed 2016, Stockholm (Sweden), Series A	Developer of monoclonal antibodies to prevent transplant rejections	$87M	3E Bioventures Capital, Yonjin Capital & 2 others	51/100
9th	GeneTex 1997, Hsinchu (Taiwan), Early Stage	GeneTex is a manufacturer and supplier of bioreagents for life science research.	$4.3M	-	49/100
10th	Immuno-Biological Laboratories 1982, Fujioka (Japan), Public	Manufacture antibodies	-	Japan Asia Investment, Whiz Partners & 3 others	49/100